Neurogenic Tests - Array-CGH Analysis

Steps Involved in IVF:

Procedure Description

Array Comparative Genomic Hybridization (Array-CGH) is a cutting-edge diagnostic tool used to detect chromosomal imbalances. It plays a critical role in identifying genetic causes of neurodevelopmental disorders such as autism spectrum disorders, intellectual disabilities, and unexplained developmental delays. Unlike traditional karyotyping, which relies on visual inspection of chromosomes, Array-CGH is more sensitive and capable of detecting micro-deletions or duplications in the genome that would otherwise go unnoticed.

In an Array-CGH test, DNA from a patient is compared to a reference DNA sample. Both DNA samples are labeled with fluorescent dyes—one color for the patient’s DNA and another for the reference. These samples are then placed on a microarray slide, where they compete to bind to corresponding DNA fragments. By measuring the intensity of fluorescence, scientists can identify whether there are any chromosomal gains or losses in the patient’s sample, thus revealing genetic abnormalities.

The Array-CGH test is commonly used to investigate unexplained developmental or neurogenic issues in children, but it is also valuable for adults who may suffer from hereditary genetic conditions. The procedure has revolutionized the detection of neurogenic conditions by offering faster, more accurate results compared to traditional diagnostic methods.

Procedure Duration

The duration of the Array-CGH process varies depending on the complexity of the case and the laboratory conducting the analysis. The procedure itself, which includes DNA extraction, labeling, hybridization, and analysis, can take anywhere from 2 to 4 days. However, the full timeline from the initial consultation to the delivery of results may take up to 1-3 weeks, depending on the location and the laboratory's workflow.

1. Pre-procedure consultation: The first step involves meeting with a genetic counselor or a specialist who will discuss the patient's medical history and determine if Array-CGH is the appropriate diagnostic tool. During this consultation, blood or saliva samples are typically collected for DNA extraction.

2. Laboratory analysis: Once the sample is processed, the DNA is extracted, labeled with fluorescent dyes, and placed onto a microarray chip for hybridization. This step can take several hours, and the hybridization process may need to run overnight for the best results.

3. Post-analysis: After the hybridization, results are analyzed by specialized software, and the data is interpreted by a geneticist. The findings are then shared with the patient during a follow-up consultation. The interpretation of the results is complex and may require further investigation to confirm a diagnosis or guide treatment options.

Recovery is not required, as this is a non-invasive diagnostic test. Patients can resume normal activities immediately after providing their sample, though emotional support may be necessary while awaiting results, especially for parents of children undergoing neurogenic testing.

Benefits

  • High Sensitivity: Array-CGH detects smaller chromosomal abnormalities compared to traditional karyotyping, enabling earlier and more precise diagnoses.
  • Comprehensive Analysis: Provides a broad genomic overview, detecting both deletions and duplications, essential for diagnosing complex neurogenic conditions.
  • Non-invasive: Only a blood or saliva sample is required, making the procedure safe and convenient for patients of all ages.
  • Speed of Results: Delivers faster results compared to older techniques, potentially reducing the time to diagnosis and treatment planning.
  • Personalized Care: The detailed genetic information can guide personalized treatment plans and genetic counseling, improving patient outcomes.

Potential Destinations

  • Germany
    Germany is known for its advanced healthcare infrastructure and cutting-edge laboratories specializing in genetic testing. Its regulatory framework ensures high standards, making it an ideal destination for patients seeking reliable neurogenic testing like Array-CGH.
  • United States
    The U.S. offers some of the most sophisticated genetic research facilities globally, with many institutions being leaders in neurogenic disorder diagnostics. Advanced technologies and a broad network of specialists make it a popular choice for patients.
  • India
    India has rapidly developed a reputation for providing high-quality medical diagnostics at more affordable prices. Many of its laboratories are equipped with the latest genetic testing technologies, and it attracts medical tourists due to the cost-effectiveness and quality care.
  • South Korea
    South Korea’s healthcare system is known for being technologically advanced and patient-centric. With its emphasis on precision medicine, South Korea is an attractive destination for genetic tests like Array-CGH, especially for international patients.
  • Spain
    Spain has emerged as a key player in medical tourism due to its world-class healthcare facilities and skilled professionals in the field of genomics. Spain offers competitive prices for genetic testing, including Array-CGH, without compromising quality.

Risks & Considerations

  • False Positives/Negatives: While highly accurate, Array-CGH can sometimes yield false positives or negatives, leading to unnecessary anxiety or missed diagnoses. Further tests may be required to confirm the findings.
  • Interpretation Complexity: The data obtained from Array-CGH tests can be complex, and misinterpretation could lead to either overdiagnosis or underdiagnosis of a condition.
  • Emotional Impact: Receiving genetic information that may indicate a severe neurogenic disorder can be emotionally overwhelming, particularly for parents. Counseling is often recommended alongside testing.
  • Availability: Array-CGH may not be available in all regions, necessitating travel to specialized centers, which could increase costs and logistical complications.
  • Cost: Depending on the location, the cost of Array-CGH testing can vary widely. Patients should ensure that the price is transparent and includes consultation, testing, and interpretation fees.

How to Choose the Right Doctor and Hospital

Selecting the right doctor and hospital for genetic testing like Array-CGH is essential for accurate results and comprehensive care. Look for a healthcare provider that has substantial experience in genetics and a specialized team to interpret the results correctly. When researching hospitals, it's crucial to focus on those with dedicated genetic counseling services and a solid reputation for handling complex cases.

Patients should also ensure that the facility is equipped with the latest diagnostic technologies and that the staff is proficient in working with cutting-edge tools like Array-CGH. Additionally, opting for hospitals that offer a multidisciplinary approach—where specialists such as neurologists, geneticists, and counselors collaborate—can enhance patient care by providing holistic guidance based on the test results.

To receive a free quote for this procedure please click on the link: https://www.medicaltourism.com/get-a-quote

Patients are advised to seek hospitals that are accredited by Global Healthcare and only work with medical tourism facilitators who are certified by Global Healthcare Accreditation or who have undergone certification from the Certified Medical Travel Professionals (CMTP). This ensures that the highest standards in the industry are met. GHA accredits the top hospitals in the world. These are the best hospitals in the world for quality and providing the best patient experience. Click the link to check out hospitals accredited by the Global Healthcare Accreditation: https://www.globalhealthcareaccreditation.com

Frequently Asked Questions

What actually happens during hyperstimulation of the ovaries?

The patient will take injectable FSH (follicle stimulating hormone) for eight to eleven days, depending on how long the follicles take to mature. This hormone is produced naturally in a woman’s body causing one egg to develop per cycle. Taking the injectable FSH causes several follicles to develop at once, at approximately the same rate. The development is monitored with vaginal ultrasounds and following the patient’s levels of estradiol and progesterone. FSH brand names include Repronex, Follistim, Menopur, Gonal-F and Bravelle. The patient injects herself daily.

What happens during egg retrieval?

When the follicles have developed enough to be harvested, the patient attends an appointment  where she is anesthetized and prepared for the procedure. Next, the doctor uses an ultrasound probe to guide a needle through the vaginal wall and into the follicle of the ovary. The thin needle draws the follicle fluid, which is then examined by an embryologist to find the eggs. The whole process takes about 20 minutes.

What happens to the eggs?

In the next step, the harvested eggs are then fertilized. If the sperm from the potential father, or in some cases, anonymous donor, has normal functionality, the eggs and sperm are placed together in a dish with a nutrient fluid, then incubated overnight to fertilize normally. If the sperm functionality is suboptimal, an embryologist uses Intracytoplasmic Sperm Injection to inject a single sperm into a single egg with an extremely precise glass needle.  Once fertilization is complete, the embryos are assessed and prepared to be transferred to the patient’s uterus.

How are the embryos transferred back to the uterus?

The doctor and the patient will discuss the number of embryos to be transferred. The number of successfully fertilized eggs usually determines the number of eggs to be placed in the uterus. Embryos are transferred to the uterus with transabdominal ultrasound guidance. This process does not require anesthesia, but it can cause minor cervical or uterine discomfort. Following transfer, the patient is advised to take at least one days bed rest and two or three additional days of rest, then 10 to 12 days later, two pregnancy tests are scheduled to confirm success. Once two positive tests are completed, an obstetrical ultrasound is ordered to show the sac, fetal pole, yolk sac and fetal heart rate.

Embryoscope©

Built into this technology there is a microscope with a powerful camera that allows the uninterrupted monitoring of the embryo during its first hours of life. In this way, we can keep a close eye on the embryo, from the moment when the oocyte is inseminated and begins to divide into smaller and smaller cells, until it can be transferred to the uterus.

Orthopedics Stem Cell

Knee

Research on mesenchymal stem cells regenerative properties in knee osteoarthritis. In these studies, researchers suggest that Stem Cell Therapy has the potential to regenerate lost cartilage, stop and reverse cartilage degeneration, provide pain relief, and improve patient mobility.

Shoulder

Stem Cell Therapy as an Alternative to Rotator Cuff & Shoulder Replacement Surgery. Stem cell therapy may offer an excellent alternative for patients looking to avoid shoulder joint replacement surgery, as well as many other surgical treatments for shoulder pain.

Ankle

If you suffer from chronic or acute ankle pain or instability due to arthritis, cartilage loss, ligament strain or tear, or tendon damage, then you may benefit from non-surgical stem cell treatments or stem cell-enhanced surgery.

Back Pain

Patients now have a minimally invasive option. Stem cell therapy for back pain and disc herniations can potentially repair the damaged disc or facet joint, restore function, rehydrate the disc, and ultimately alleviate chronic pain.

Anti-Aging Stem Cell

Hair Loss

Stem cell therapy and PRP therapy have been shown to be most effective for: Those in the early stages of hair loss, patients who are not viable candidates for surgery and women who prefer to avoid hair surgery.

Facial Anti-Aging

Aesthetic Anti-Aging. The Aesthetic Stem Cell Localized Treatment is a non-surgical minimally invasive procedure to enhance the appearance of aging skin and hair restoration. This all-natural technique combines dermal injections of bone marrow or adipose tissue derived stem cells and growth factors.

Fertility Stem Cell

Endometrial PRP

The stem cells used for treatment of a thin endometrium include mesenchymal stem cells. In addition, successful repair of the endometrium in pregnancy with stem cells has been reported previously.

Low Ovarian Reserve (PRP)

The treatment uses PRP (Platelet-Rich-Plasma), which with stem cell therapy is the novel therapeutic approach for restoring the quality of the ovarian reserve.Your PRP will contain a physiologic balance of platelets, growth factors and white blood cells tailored specifically for you.

Destinations offering this treatment:
Featured provider offering this treatment:
Providers offering this treatment:
Facilitators offering this treatment:
No items found.